<VariationArchive VariationID="3069156" VariationName="NM_000214.3(JAG1):c.1813del (p.Cys605fs)" VariationType="Deletion" Accession="VCV003069156" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-20" DateCreated="2024-04-20" MostRecentSubmission="2024-04-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3228481" VariationID="3069156">
      <GeneList>
        <Gene Symbol="JAG1" FullName="jagged canonical Notch ligand 1" GeneID="182" HGNC_ID="HGNC:6188" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20p12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="10637684" stop="10673999" display_start="10637684" display_stop="10673999" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="10618331" stop="10654693" display_start="10618331" display_stop="10654693" Strand="-" />
          </Location>
          <OMIM>601920</OMIM>
          <Haploinsufficiency last_evaluated="2020-10-19" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=JAG1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-10-19" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=JAG1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000214.3(JAG1):c.1813del (p.Cys605fs)</Name>
      <CanonicalSPDI>NC_000020.11:10647010:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20p12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="10647011" stop="10647011" display_start="10647011" display_stop="10647011" variantLength="1" positionVCF="10647010" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="10627659" stop="10627659" display_start="10627659" display_stop="10627659" variantLength="1" positionVCF="10627658" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>C605fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.10627659del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.10627659del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.10647011del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.10647011del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007496.1" sequenceAccession="NG_007496" sequenceVersion="1" change="g.32036del">
            <Expression>NG_007496.1:g.32036del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000214.3" sequenceAccession="NM_000214" sequenceVersion="3" change="c.1813del" MANESelect="true">
            <Expression>NM_000214.3:c.1813del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000205.1" sequenceAccession="NP_000205" sequenceVersion="1" change="p.Cys605fs">
            <Expression>NP_000205.1:p.Cys605fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1191" sequenceAccession="LRG_1191">
            <Expression>LRG_1191:g.32036del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1191t1" sequenceAccession="LRG_1191t1">
            <Expression>LRG_1191t1:c.1813del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1191p1" sequenceAccession="LRG_1191p1" change="p.Cys605fs">
            <Expression>LRG_1191p1:p.Cys605fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000214.3(JAG1):c.1813del (p.Cys605fs) AND Alagille syndrome due to a JAG1 point mutation" Accession="RCV004006216" Version="1">
        <ClassifiedConditionList TraitSetID="2076">
          <ClassifiedCondition DB="MedGen" ID="C1956125">Alagille syndrome due to a JAG1 point mutation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-23" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-04-20" MostRecentSubmission="2024-04-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="2076" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="142" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Alagille syndrome due to a JAG1 point mutation</ElementValue>
                <XRef ID="MONDO:0016862" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEPATIC DUCTULAR HYPOPLASIA, SYNDROMATIC</ElementValue>
                <XRef Type="MIM" ID="118450" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">JAG1-Related Alagille Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alagille syndrome 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AHD</ElementValue>
                <XRef Type="MIM" ID="118450" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AWS</ElementValue>
                <XRef Type="MIM" ID="118450" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ALGS1</ElementValue>
                <XRef Type="MIM" ID="118450" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Alagille syndrome (ALGS) is a multisystem disorder with a wide spectrum of clinical variability; this variability is seen even among individuals from the same family. The major clinical manifestations of ALGS are bile duct paucity on liver biopsy, cholestasis, congenital cardiac defects (primarily involving the pulmonary arteries), butterfly vertebrae, ophthalmologic abnormalities (most commonly posterior embryotoxon), and characteristic facial features. Renal abnormalities, growth failure, developmental delays, splenomegaly, and vascular abnormalities may also occur.</Attribute>
                <XRef ID="NBK1273" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17251" />
                <XRef ID="17251" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301450</ID>
                <ID Source="BookShelf">NBK1273</ID>
              </Citation>
              <XRef ID="261619" DB="Orphanet" />
              <XRef ID="52" DB="Orphanet" />
              <XRef ID="C1956125" DB="MedGen" />
              <XRef ID="MONDO:0016862" DB="MONDO" />
              <XRef Type="MIM" ID="118450" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9000435" SubmissionDate="2024-04-12" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey=":Chr.20_10627658_CA_C|OMIM:118450" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004814142" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The JAG1 c.1813delT p.(Cys605AlafsTer138) variant causes a shift in the protein reading frame that is predicted to result in premature termination of the protein. Loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay is expected. To our knowledge, this variant has not been reported in the peer-reviewed literature. This variant is not found in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. This variant was identified in a de novo state in the proband. Based on the available evidence, the c.1813delT p.(Cys605AlafsTer138) variant is classified as pathogenic for Alagille syndrome.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSLVariantClassificationCriteria RUGD 01 April 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/dy7elfgy/icslvariantclassificationcriteria_rugd_01_april_2020.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="20" alternateAllele="C" referenceAllele="CA" start="10627658" stop="10627659" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="118450" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14375523</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9000435" TraitType="Disease" MappingType="XRef" MappingValue="118450" MappingRef="OMIM">
        <MedGen CUI="C1956125" Name="Alagille syndrome due to a JAG1 point mutation" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

